Morphological organization of thrombus after endovascular thrombus extraction in patients with ischemic heart disease
- Authors: Zatolokina M.A.1,2, Gorbunova M.V.1, Snimshchikova I.A.1, Reviakina M.O.1, Erofeev A.V.2, Konshina A.V.3, Sadуgov G.N.2, Ryzhenkov I.A.2, Filipskikh D.A.2
-
Affiliations:
- I.S. Turgenev Orel State University
- Kursk State Medical University
- N.N. Priorov National Medical Research Center of Traumatology and Orthopedics
- Issue: Vol 22, No 4 (2025)
- Pages: 158-164
- Section: Original Researches
- URL: https://ogarev-online.ru/1994-9480/article/view/375662
- DOI: https://doi.org/10.19163/1994-9480-2025-22-4-158-164
- ID: 375662
Cite item
Full Text
Abstract
Relevance: Ischemic heart disease (IHD) claims the lives of approximately 18 million people annually. The vascular damage that occurs during this process is the primary cause of clinical manifestations, with the thrombus being one of the material substrates. Venous and atherothrombosis initiate inflammation with the participation of immune cells, cytokines, and chemokines. Therefore, understanding the molecular and cellular mechanisms of thrombosis is crucial and requires further research to address this issue. Furthermore, studying the morphological features of the removed thrombus and identifying the specific cell type that forms it will help identify potential predictors of the risk of complications during thrombosis treatment. The aim of this study was to investigate the morphological and immunohistochemical characteristics of thrombi after endovascular thrombectomy in patients with coronary artery disease.
Materials and methods: Morphological examination was performed on biopsy specimens obtained by aspiration of thrombotic masses from the occluded artery. The obtained biomaterial was fixed in 10 % buffered neutral formalin and embedded in paraffin using standard techniques. Histological sections were prepared and stained with hematoxylin and eosin, using the Picro-Mallory method, and immunohistochemistry was performed using monoclonal antibodies to CD68, CD45RA, and MPO. All obtained slides were examined under a light microscope and photographed. Morphometric analysis was performed using ImagoJ software, and statistical processing was performed using the MS Excel 2010 statistical analysis package.
Results: The quality of thrombus organization and the rate of its formation depend on the duration and severity of coronary heart disease. The observed maximum leukocyte count on the first day, primarily due to neutrophils, and the maximum surface area (61.2 %) occupied by fibrin indicate an early stage of thrombus organization. A dynamic two-fold decrease in neutrophils and a 1.5-fold increase in macrophages, accompanied by a 1.6-fold decrease in the area occupied by fibrin on day 3, indicated active thrombus resorption and tissue remodeling – an intermediate stage of thrombus organization. A 2.2-fold decrease in macrophages, accompanied by a significant 1.9-fold increase in endothelial cells and fibroblasts and minimal fibrin area (a 2.9-fold decrease compared to day 3) on day 7, indicated the formation of granulation tissue, scar tissue, vascular wall remodeling, and active angiogenesis – a late stage of thrombus organization.
Conclusions: The obtained morphological data regarding the cellular component of the thrombus complement the picture of thrombosis dynamics and can be considered when developing strategies to improve preventive and therapeutic measures for patients with coronary artery disease.
Keywords
About the authors
Maria A. Zatolokina
I.S. Turgenev Orel State University; Kursk State Medical University
Author for correspondence.
Email: marika1212@mail.ru
ORCID iD: 0000-0002-9553-1597
MD, Professor of the Department of Histology, Embryology and Cytology, Head of the Department of Histology, Cytology, and Embryology, Medical Institute
Russian Federation, Orel; KurskMarina V. Gorbunova
I.S. Turgenev Orel State University
Email: gorbynovamv@ya.ru
ORCID iD: 0000-0001-5808-7047
Candidate of Medical Sciences, Associate Professor of the Department of Histology, Cytology and Embryology, Medical Institute
Russian Federation, OrelIrina A. Snimshchikova
I.S. Turgenev Orel State University
Email: snimshikova@mail.ru
ORCID iD: 0000-0002-4258-963X
MD, Professor, Leading Researcher at the Laboratory of New Medical Technologies, Head of the Department of Immunology and Specialized Clinical Disciplines, Director, Medical Institute
Russian Federation, OrelMariia O. Reviakina
I.S. Turgenev Orel State University
Email: revyakina_masha@mail.ru
ORCID iD: 0000-0003-1593-5290
PhD, Leading Researcher at the Laboratory of Molecular, Translational and Digital Cardioimmunology, Senior Researcher at the Laboratory of New Medical Technologies, Associate Professor at the Department of Immunology and Specialized Clinical Disciplines, Medical Institute
Russian Federation, OrelAnatoly V. Erofeev
Kursk State Medical University
Email: erofeev.erofeevtolik@yandex.ru
ORCID iD: 0000-0003-0593-9087
4th year student of the Faculty of Medicine
Russian Federation, KurskAnna V. Konshina
N.N. Priorov National Medical Research Center of Traumatology and Orthopedics
Email: Astro.cito@ya.ru
ORCID iD: 0009-0000-0353-0849
Candidate of Biological Sciences, Associate Professor of the Department of Traumatology, Orthopedics and Related Disciplines, Head of the Department for Educational Activities
Russian Federation, MoscowGabib N. Sadуgov
Kursk State Medical University
Email: gabibsadygov97@gmail.com
ORCID iD: 0000-0002-5267-0503
5th year student of the Faculty of Medicine
Russian Federation, KurskIvan A. Ryzhenkov
Kursk State Medical University
Email: ivan.ryzhenkov.03@inbox.ru
ORCID iD: 0000-0002-8217-9176
5th year student of the Faculty of Medicine
Russian Federation, KurskDmitry A. Filipskikh
Kursk State Medical University
Email: FilipskikhDmitry@yandex.ru
ORCID iD: 0009-0004-0845-4821
5th year student of the Faculty of Medicine
Russian Federation, KurskReferences
- Vaisman D.Sh., Enina E.N. Mortality rates from coronary heart disease in the Russian Federation and a number of regions: dynamics and structure features. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy And Prevention. 2024;23(7):3975. (In Russ.) doi: 10.15829/1728-8800-2024-3975.
- Bichurin D.R., Atmaikina O.V., Cherepanova O.A. Cardiovascular diseases. The regional aspect. Mezhdunarodnyi nauchno-issledovatel'skii zhurnal = International Research Journal. 2023;8(134). (In Russ.) doi: 10.23670/IRJ.2023.134.103.
- Chernyavsky A.M., Chernyavsky M.A., Fomichev A.V., Doronin D.V. Successful endovascular thromboextraction from the right atrium with a massive fixed thrombus of the right heart. Flebologiya = Journal of Venous Disorders. 2015;9(3):47–52. (In Russ.) doi: 10.17116/flebo20159347-50.
- Shumakov D.V., Shekhyan G.G., Zybin D.I., Yalymov A.A., Stepina E.V., Popov M.A. Late complications of percutaneous coronary interventions. Russkii meditsinskii zhurnal = Russian Medical Journal. 2020;10:25–28. (In Russ.) doi: 10.23670/IRJ.2023.14.113.
- Zatolokina M.A., Gorbunova M.V., Snimshchikova I.A., Plotnikova M.O., Erofeev A.V. Morphological characteristics of the tissues of the cardiovascular system that determine the criteria for the diagnosis of coronary heart disease. Vestnik Volgogradskogo gosudarstvennogo meditsinskogo universiteta = Journal of Volgograd State Medical University. 2025;1(22): 61–68. (In Russ.) doi: 10.19163/19949480-2025-22-1-61-68.
- Sisakyan A.S., Mkhitaryan A.G., Sahakyan V.G., Kocharyan A.S., Asatryan B.A. Morphological and immunohistochemical characteristics of blood clots aspirated from vessels in patients with ST segment elevation myocardial infarction. Terapevticheskii arkhiv = Therapeutic Archive. 2019;91(9):21–25. (In Russ.) doi: 10.26442/00403660.2019.09.000199.
- Khismatullin R.R., Ivaeva R.A., Abdullayeva Sh., Shakirova A.Z., Khuzin F.F., Kiyasov A.P. et al. Pathomorphological manifestations of inflammatory microthrombosis in COVID-19. Kazanskii meditsinskii zhurnal = Kazan Medical Journal. 2022;103(4):575–586. (In Russ.) doi: 10.17816/KMJ2022-575.
- Rawish Е., Nording Н., Münte Т., Langer Н.F. Platelets as mediators of euroinflammation and thrombosis. Frontiers in Immunology. 2020;11. doi: 10.3389/FIMMU.2020.548631.
- Nardia А.С., Coy-Canguçua А., Saitoa А., Florioa М., Martia G., Degasperia G. et al. Orsib. Immunothrombosis and its underlying biological mechanisms. Hematology, Transfusion and Cell Therapy. 2024;46(1):49–57. doi: 10.1016/j.htct.2023.05.008.
Supplementary files

